PPBT

Purple Biotech
PPBT

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $134K invested in Purple Biotech in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$32.6K
2
+$544
3
+$226

Top Sellers

1
-$72.1K
2
-$44.3K
3
-$40.2K
4
Morgan Stanley
Morgan Stanley
New York
-$1.73K
5
CWM
Crowley Wealth Management
Delaware
-$1.41K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$61.2K
KWA
2
Kingswood Wealth Advisors
California
$44.3K
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$14.3K
Morgan Stanley
4
Morgan Stanley
New York
$11.9K
RhumbLine Advisers
5
RhumbLine Advisers
Massachusetts
$2.19K
Northwestern Mutual Wealth Management
6
Northwestern Mutual Wealth Management
Wisconsin
$226
SS
7
SBI Securities
Japan
$53
NSIM
8
North Star Investment Management
Illinois
$40
TSS
9
Two Sigma Securities
New York
–
Group One Trading
10
Group One Trading
Illinois
–
CWM
11
Crowley Wealth Management
Delaware
–
TRCT
12
Tower Research Capital (TRC)
New York
–
TWC
13
TD Waterhouse Canada
Ontario, Canada
–